January 26-28th, 2015
Benefit-Risk in 2015! Regulatory science, tools, realities, and perceptions of biopharmaceutical product benefit-risk continue to evolve across the global pharmacovigilance landscape. During this three-day meeting, thought leaders from around the world will provide their insight and engage in dialogue on current opportunities and challenges in managing product risk in the context of benefit. The current regulatory framework will be outlined and practical approaches to protecting patient safety will be discussed.
This event will provide a unique setting for informal dialogue with representatives from FDA and other key regulatory agencies, as well as from industry and academia. There will be multiple opportunities for participants to engage speakers and interact with fellow colleagues.
- Keynote Presentation by Professor Stephen Evans of the London School of Hygiene & Tropical Medicine
- Luncheon Roundtable Discussions
- Tabletop Exhibits
- Pre-meeting Tutorial Offerings